| 2-AG | 2-arachidonoylglycerol |
| AEA | Anandamide |
| AKI | Acute kidney injury |
| AMI | Acute myocardial infarction |
| ARA | Arachidonic acid |
| ATN | Acute tubular necrosis |
| CB | Cannabinoid receptor |
| CB1 | Cannabinoid receptor 1 |
| CB2 | Cannabinoid receptor 2 |
| CBC | Cannabichromene |
| CBD | Cannabidiol |
| CBE | Cannablesoin, |
| CBG | Cannabigerol |
| CBL | Cannabicyclol |
| CBM | Cannabinoid-based medication |
| CBN | Cannabinol |
| CBND | Cannabinodiol |
| CBT | Cannabitriol |
| CGRP | Calcitonin gene-related peptide |
| CKD | Chronic kidney disease |
| CNS | Central nervous system |
| COX | Cyclooxygenase |
| CUD | Cannabis use disorder |
| CYP | Cytochrome P450 |
| DAG | DIacyloglycerol |
| DM | Diabetes mellitus |
| DN | Diabetic nephropathy |
| ERKs | Extracellular signal-regulated kinases |
| eGFR | Estimated glomerular filtration rate |
| FAAH | Fatty acid amide hydrolase |
| FXR | Farnesoid X receptor |
| GFR | Glomerular filtration rate |
| GPCR | G protein coupled receptor |
| IR | Ischemia and reperfusion |
| JNKs | C-Jun N-terminal kinases |
| LPS | Lipopolysaccharide |
| MAPK | Mitogen-activated protein kinase |
| NADA | N-arachidonoyl dopamine |
| NAPE | N-arachidonoyl phosphatidylethanolamine |
| PIP2 | 4,5-bisphosphate |
| PE | Phosphatidylethanolamine |
| PPAR | Peroxisome proliferator-activated receptor |
| PLC | Phospholipase C |
| SCs | Synthetic cannabinoids |
| THC | Delta-9-tetrahydrocannabinol |
| TLR | Toll-like receptor |
| TRPV1 | Transient receptor potential cation channel vanilloid 1 |
| Δ8-THC | Δ8 -trans-tetrahydrocannabinol |
| 11-OH-THC | 11-Hydroxy-Δ9-tetrahydrocannabinol |
| 11-COOH-THC | 11-Nor-9-carboxy-Δ9-tetrahydrocannabinol |
| 7-OH-CBD | 7-Hydroxy-CBD |